RANI BERRY

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology BURLINGAME, CA NPI 1821521774

General Payments — all program years on this page

$2,058.15

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $747.30 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $721.7121
Education $25.591

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $817.0710
2023 $493.788
2024 $747.3022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075848851 Celltrion USA Inc. $25.59 02/01/2024 Education Undisputed 01/23/2026 View at CMS
1075848853 Celltrion USA Inc. $27.83 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078289673 Janssen Biotech, Inc. $28.42 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078289703 Janssen Biotech, Inc. $30.89 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078289733 Janssen Biotech, Inc. $39.94 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316110 ABBVIE INC. $14.34 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316112 ABBVIE INC. $8.01 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316114 ABBVIE INC. $27.20 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316116 ABBVIE INC. $28.29 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316118 ABBVIE INC. $17.78 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316120 ABBVIE INC. $125.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103316122 ABBVIE INC. $37.91 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131267563 PFIZER INC. $23.23 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131326641 PFIZER INC. $22.98 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135329032 Lilly USA, LLC $124.83 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135331796 Lilly USA, LLC $33.59 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141714144 Merck Sharp & Dohme LLC $23.86 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146958057 Fresenius Kabi USA, LLC $31.77 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146987957 AIMMUNE THERAPEUTICS, INC. $16.63 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147724904 QOL Medical, LLC $20.91 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147724906 QOL Medical, LLC $19.77 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151040126 Phathom Pharmaceuticals, Inc. $18.53 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.